|
|
|||||||
877B850 |
1 Oftalmologia, Universidad de Murcia, Murcia, Spain
2 Biological Sciences, Allergan Inc., Irvine, CA
Commercial Relationships: S. MayorTorroglosa, None; E. WoldeMussie, Allergan Inc. E; G. Ruiz, Allergan Inc. E; A. GarcíaAvilés, None; J.M. Bernal, None; L.A. Wheeler, Allergan Inc. E; M. VidalSanz, Allergan Inc. F.
Grant Identification: PI82/00540/FS/01, BFI200203742, Allergan Inc.
Abstract
Purpose: To study the effects of chronic ocular hypertension on retinotectal afferents, and the neuroprotective effects of topically applied AlphaganP ®, Timoptic ® or saline.
Methods: In adult male Wistar rats (350450 g), ocular hypertension (OHT) was induced in the right eye by laser photocoagulation of episcleral veins following already described techniques (WoldeMussie et al., 2001; IOVS 42:2849). Right after first laser treatment, the right eyes were treated topically twice daily with 5 µl of AlphaganP, Timoptic or 0,9% NaCl. Intraocular pressure was measured with a tonopen prior to, 7 and 14 days after lasering in experimental and an additional group of unlesioned (naïve) animals. Retinotectal afferents were identified with the orthogradely transported tracer cholera toxin subunit B (CTB), injected 5 days prior to sacrifice, in the vitreous of the right eye of experimental and naïve animls. Serial coronal sections (40 µm thick) of the midbrain were inmunostained for CTB. The visual layers of the contralateral superior colliculus (SC) were examined with the aid of an image analysis system, to estimate the volume of the retinotectal projection.
Results: Photocoagulation of episcleral and limbal veins results two weeks later in twofold increased intraocular pressure (IOP) in the salinetreated group of animals (32.4±1.5; n=7) as compared to the naïve group of animals (15.5±0.6; n=8). Both AlphaganP and Timoptic were similarly effective in diminishing the rise of IOP after laser treatment. Laserinduced OHT in the AlphaganP or Timpoptictreated groups of animals was smaller than that of the salinetreated group of animals (p<0.05) and greater than that of the unlesioned naïve group of animals (p<0.05). The volume of the retinotectal projection was 4.10±0.39 (n=8), 3.56±0.23 (n=7), 3.56±0.51 (n=8), or 3.87±0.34 (n=7), for the naïve, saline, AlphaganP, or Timololtreated groups of rats, respectively.
Conclusions: OHT induces within three weeks the loss of approximately 13% of the retinotectal terminals, Timoptic treatment did not prevent retinotectal degeneration, and AlphaganPtreatement provided a statistically significant protection against OHTinduced degeneration of the retinotectal projection.
Keywords: neuroprotection ganglion cells intraocular pressure
© 2004, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. For permission to reproduce any part of this abstract, contact the ARVO Office at arvo{at}arvo.org.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |